The human identification market is segmented based on product & service, technology, application, and end user. Since product & service, the market is segmented into consumables, services, instruments, and software. The consumables segment is expected to account for the largest share of the market in 2017. The growth in this segment is primarily attributed to regular and bulk purchases of consumables coupled with product launches.
Based on technology, the global human identification market is segmented into polymerase chain reaction (PCR), next-generation sequencing (NGS), capillary electrophoresis, nucleic acid isolation and purification, automated liquid handling, microarrays, and rapid DNA analysis. In 2017, the capillary electrophoresis segment accounted for the largest share of the market. Its high efficiency, faster analysis, and requirement of a small volume of solvents are driving the uptake of this technology in human identification.
Sample Report – https://www.marketsandmarkets.com/requestsampleNew.asp?id=100607777
This report aims to provide insights into the global human identification market. It provides valuable information on human identification product & service, technology, applications, and end users. Details on regional markets for these segments have also been presented in this report. In addition, leading players in the market are profiled to understand the strategies undertaken by them to be competitive in this market.
Based on application, the human identification market is segmented into forensic applications, paternity identification, and other applications. In 2017, the forensic application segment is expected to account for the largest share of the global market. The increasing crime rate across the globe is one of the major factors driving the growth of this segment.
Major Leading Players:
Key players operating in the human identification market include Thermo Fisher Scientific Inc. (US), QIAGEN N.V. (Netherlands), Promega Corporation (US), Agilent Technologies Inc. (US), General Electric Company (GE Healthcare) (US), Laboratory Corporation of America Holdings (US), Illumina, Inc. (US), LGC Limited (US), Eurofins Scientific (Luxembourg), NMS Labs Inc. (US), IntegenX Inc. (US), Hamilton Company (US), PerkinElmer, Inc. (US), Bio-Rad Laboratories, Inc. (US), Alere (US), Tecan Trading AG (Switzerland), Ciro Manufacturing Corporation (US), Key Forensic Services Limited (UK), Sorenson Forensics (US), Parseq Lab s.r.o. (Czech Republic), DNA Diagnostics Center (US), PT&C Forensic Consulting Services P.A. (Envista Forensics) (UK), InnoGenomics Technologies, LLC. (US), Trinity DNA Solutions (US), and Genex Diagnostics, Inc. (US).
